EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alterations in gut microbiota and inflammatory cytokines after administration of antibiotics in mice

Wang Gao, Xingyu Liu, Shuobo Zhang, Jingxia Wang, Bo Qiu, Junhua Shao, Weixin Huang, Yilun Huang, Mingfei Yao iD, Ling-Ling Tang iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.03095-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Wang Gao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Cytokines, Anti-Bacterial Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | Shandong Provincial Laboratory Project, Research Project of Jinan Microecological Biomedicine Shandong Laboratory, MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics are widely used to treat bacterial infection and reduce the mortality rate, while antibiotic overuse can cause gut microbiota dysbiosis. The impact of antibiotics on gut microbiota is not fully understood. In our study, four commonly used antibiotics (ceftazidime, cefoperazone-sulbactam, imipenem-cilastatin, and moxifloxacin) were given subcutaneously to mice, and their impacts on the gut microbiota composition and serum cytokine levels were evaluated through 16S rRNA analysis and a multiplex immunoassay. Antibiotic treatment markedly reduced gut microbiota diversity and changed gut microbiota composition. Antibiotic treatment significantly increased and decreased the abundance of Firmicutes and Bacteroidota, respectively. The antibiotic treatments increased the abundance of opportunistic pathogens such as Enterococcus and decreased that of Lachnospiraceae and Muribaculaceae . For moxifloxacin, the significantly high abundance of Enterococcus and Klebsiella was observed after 14 and 21 days of treatment. However, a relatively low abundance of opportunistic pathogens was found after 14 days of imipenem-cilastatin treatment. Additionally, the serum levels of various pro-inflammatory cytokines, such as IL-1β, IL-12 (p70), and IL-17, significantly increased after 21 days of antibiotic treatments. Overall, these results provide a guide for rational use of antibiotics in clinical settings: short-term use of moxifloxacin is recommended with regard to gut microbiota health, and the 14-day use of imipenem-cilastatin may have a less severe impact than other antibiotics. IMPORTANCE Antibiotic treatments are directly associated with changes in gut microbiota and are effective against both pathogens and beneficial bacteria. Gut microbiota dysbiosis induced by antibiotic treatment could increase the risk of some diseases. Therefore, an adequate understanding of gut microbiota changes after antibiotic use is crucial. In this study, we investigated the effects of continuous treatment with antibiotics on gut microbiota, serum cytokines, and intestinal inflammatory response. Our results suggest that short-term use of moxifloxacin is recommended, and the 14-day use of imipenem-cilastatin may have a less severe effect on gut microbiota health than cefoperazone-sulbactam. These results provide useful guidance on the rational use of antibiotics with regard to gut microbiota health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeCytokinesAnti-Bacterial AgentsAnimalsMiceBacteriaDysbiosisRNA, Ribosomal, 16SCefoperazoneMaleMoxifloxacinFemaleMice, Inbred C57BL

Stichwörter der Autor:innen

antibioticcytokinedysbiosisgut microbiotainflammatory response

Substanzen

CytokinesAnti-Bacterial AgentsRNA, Ribosomal, 16SCefoperazoneMoxifloxacin

Autor:innen und Institutionen

  • Jinan Microecological Biomedicine Shandong Laboratory, Jinan, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The…
  • Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China.
  • Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University, Shulan International Medical College, Hangzhou, China.
  • Shaoxing Tongchuang Biotechnology Co., Ltd, Shaoxing, China.
  • Alberta Institute, Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Mingfei Yao, Ling-Ling Tang

Förderung

  • MOST | Shandong Provincial Laboratory Project
  • Research Project of Jinan Microecological Biomedicine Shandong Laboratory
  • MOST | National Key Research and Development Program of China (NKPs)

Zitieren

APA

Gao, W., Liu, X., Zhang, S., Wang, J., Qiu, B., Shao, J., Huang, W., Huang, Y., Yao, M., & Tang, L. L. (2024). Alterations in gut microbiota and inflammatory cytokines after administration of antibiotics in mice. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03095-23

Vancouver

Gao W, Liu X, Zhang S, Wang J, Qiu B, Shao J, et al. Alterations in gut microbiota and inflammatory cytokines after administration of antibiotics in mice. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03095-23

BibTeX
@article{Gao2024,
  author = {Gao, Wang and Liu, Xingyu and Zhang, Shuobo and Wang, Jingxia and Qiu, Bo and Shao, Junhua and Huang, Weixin and Huang, Yilun and Yao, Mingfei and Tang, Ling-Ling},
  title = {Alterations in gut microbiota and inflammatory cytokines after administration of antibiotics in mice},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.03095-23}
}
Kostenlos starten →